[Blood fibrinolytic activity in patients with acute leukemia and blast crisis of chronic myeloleukemia]. 1970

G A Naumova, and G V Andreenko, and L D Orlova

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G A Naumova, and G V Andreenko, and L D Orlova
April 1973, Problemy gematologii i perelivaniia krovi,
G A Naumova, and G V Andreenko, and L D Orlova
January 1986, Terapevticheskii arkhiv,
G A Naumova, and G V Andreenko, and L D Orlova
January 1984, Eksperimental'naia onkologiia,
G A Naumova, and G V Andreenko, and L D Orlova
April 1991, Vrachebnoe delo,
G A Naumova, and G V Andreenko, and L D Orlova
January 1990, Terapevticheskii arkhiv,
G A Naumova, and G V Andreenko, and L D Orlova
January 1995, Terapevticheskii arkhiv,
G A Naumova, and G V Andreenko, and L D Orlova
February 1980, Problemy gematologii i perelivaniia krovi,
G A Naumova, and G V Andreenko, and L D Orlova
January 1979, Haematology and blood transfusion,
G A Naumova, and G V Andreenko, and L D Orlova
October 1970, Problemy gematologii i perelivaniia krovi,
G A Naumova, and G V Andreenko, and L D Orlova
April 1976, JAMA,
Copied contents to your clipboard!